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Development of reagents to study the turkey’s immune response: Identiﬁcation
and molecular cloning of turkey CD4, CD8a and CD28
Fiona Powell 1, Michelle Lawson 2, Lisa Rothwell, Pete Kaiser *
Institute for Animal Health, Compton, Berkshire RG20 7NN, UK
1. Introduction
The greater economical importance of the chicken has led to
more extensive identiﬁcation of immune-related molecules in this
species than in any other avian species, including the turkey. As a
result, a wide and ever increasing range of reagents are available to
measure the chicken’s immune response. This ‘immunological
toolbox’ includes monoclonal antibodies (mAb) raised against a
number of cell surface markers in the chicken, including CD4,
CD8a and CD28, which have long enabled investigation of immune
cell subsets during infection studies. The vast majority of these
markers have yet to be cloned in the turkey.
CD4 is a surface glycoprotein principally expressed as a
monomer on T cells and thymocytes but also on macrophages
and dendritic cells. CD4 acts as a co-receptor for MHC class II
through interactions with the MHC class II a2 and b2 domains
[1,2], thus restricting Th cells to recognition of antigen presented
by MHC class II. Chicken CD4 was ﬁrst identiﬁed using mAb
produced against chicken T cells, and observing the distribution
of staining of these mAb on cells from lymphoid and haemo-
poietic tissues [3]. Chicken CD4 is expressed on the surface of
thymocytes, peripheral T cells and intestinal intraepithelial T
cells [3] and shares a similar Ig-like structure to mammalian CD4
with four extracellular Ig domains that resemble the C and V
regions of Ig [4]. With similar functions to mammalian CD4,
chicken CD4 therefore plays a crucial role in the immune
response [5].
CD8a is a surface glycoprotein expressed on cytotoxic T cells
(Tc) as a homodimer (CD8aa) or heterodimer (CD8ab). Expres-
sion of theb chain requires co-expression of thea chain [6]. CD8 is
a co-receptor for MHC class I and, in a similar manner to CD4,
restricts CD8+ cells to recognition of antigen presented by MHC
class I. CD8 binds to the a3 domain of the MHC molecule,
enhancing the interaction between the Tc cell and the antigen
presenting cell (APC). As with chicken CD4, chicken CD8awas ﬁrst
identiﬁed usingmAb produced against T cells [3]. In mammals and
the chicken, CD8aa is expressed on thymocytes, peripheral T cells,
NK cells, intestinal intraepithelial cells, and a population of
peripheral blood CD4 T cells. CD8ab is expressed, inmammals and
the chicken, on thymocytes, peripheral T cells and in the chicken
only, a subset of intestinal epithelial gd T cells [7]. As with
mammals, expression of the b chain is dependent on the presence
of the a chain [7].
CD28 is a surface glycoprotein expressed as a homodimer in
mammals, predominantly on T cells, including naı¨ve T cells, and
provides co-stimulation to other immune effector cells. CD28
acts as a co-receptor for two further molecules found on APC,
CD80 and CD86 [8]. Interactions of these molecules augment
signalling from the TCR to enhance cytokine production, in
particular IL-2 [9]. Chicken CD28 was ﬁrst cloned from a chicken
Developmental and Comparative Immunology 33 (2009) 540–546
A R T I C L E I N F O
Article history:
Received 18 August 2008
Received in revised form 25 September 2008
Accepted 2 October 2008
Available online 12 November 2008
Keywords:
Chicken
Turkey
CD marker
Cross-reactivity
A B S T R A C T
The cDNAs of three turkey CDmarkers, CD4, CD8a and CD28, were identiﬁed by screening a turkey cDNA
library. The coding regions of the chicken and turkey genes are highly conserved, with 91.3–96.1%
nucleotide (nt) and 84.2–95.5% amino acid (aa) identity. Identity was less conserved between avian CD
markers and their mammalian homologues, ranging from 44.7 to 59.8% and 22.4 to 50.4% at the nt and aa
levels, respectively. Anti-chicken CD8a and CD28 monoclonal antibodies were demonstrated to
speciﬁcally cross-react with turkey CD8a and CD28, respectively.
 2008 Elsevier Ltd. All rights reserved.
* Corresponding author. Tel.: +44 1635 577277; fax: +44 1635 577263.
E-mail address: pete.kaiser@bbsrc.ac.uk (P. Kaiser).
1 Current address: Brighton & Sussex Medical School, Medical Research Building,
University of Sussex, Brighton BN1 9PS, UK.
2 Current address: Academic Unit of Bone Biology, Section of Musculoskeletal
Science, Medical School, University of Shefﬁeld, Beech Hill Road, Shefﬁeld S10 2RX,
UK.
Contents lists available at ScienceDirect
Developmental and Comparative Immunology
journal homepage: www.e lsev ier .com/ locate /dc i
0145-305X/$ – see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.dci.2008.10.005
Author's personal copy
cDNA library by expression cloning with the mAb AV7 [10].
Expression of chicken CD28 is conserved with that of mammals,
being expressed on resting and activated T cells [11]. The
function of CD28 is also conserved between mammals and birds
[12].
There have been several reports [13–15] using anti-chicken CD
marker mAb to demonstrate cross-reactivity with turkey cells.
Certain anti-chicken CD4 and CD8a mAb cross-react with turkey
cells, but not others [13,14]. More recently, we used a similar panel
of mAb to follow cellular changes indicative of an inﬂammatory
response in the footpads of growing turkeys suffering from footpad
dermatitis [15]. However, demonstration of cross-reactivity does
not prove that it is speciﬁc to the orthologous molecule in another
species. We therefore set out to clone and sequence turkey CD4,
CD8a and CD28, and demonstrate that the cross-reactivity of the
anti-chicken CD marker mAb was speciﬁc to the orthologous CD
marker in the turkey.
2. Materials and methods
2.1. Turkey cDNA library screening
A normalised full-length turkey cDNA librarywas commercially
constructed (GATC Biotech AG, Cambridge, UK) from combined
turkey RNA isolated from spleen, thymus and bursa in this
laboratory, so that the library contained asmany immune-relevant
cDNA sequences as possible. Inserts were directionally cloned into
the pBluescript II SK+ vector with a modiﬁed multiple cloning site
and electroporated into E. coli XL1-Blue MRF0 cells. The cDNA
library was provided as a set of three gridded ﬁlters by ARK-
Genomics (Roslin Institute, Roslin, UK).
Partial length turkey cDNA clones generated in this laboratory
previously [16] were labelled with a32P-dCTP using a random-
primed DNA labelling kit (Roche, Lewes, UK) and puriﬁed using
Illustra ProbeQuant G-50 Micro Columns (GE Healthcare Life
Sciences, Little Chalfont, UK) to remove all unincorporated labelled
nucleotides from the reaction. The puriﬁed probes were used to
screen the turkey cDNA library. Positive clones were isolated,
puriﬁed and then sequencedwith a CEQ 8000 sequencer (Beckman
Coulter, High Wycombe, UK), analysed for potential turkey
cytokine sequences using DS Gene (Accelrys, Cambridge, UK)
and Vector NTI (Invitrogen, Paisley, UK), and compared to the
relevant chicken cDNA sequences. Sequences were submitted to
best local alignment search tool (BLAST) searches through the
Ensembl BLAST facility (www.ensembl.org).
Sequence-speciﬁc primers were then used to generate PCR
products for cloning into pCI-neo and expression in COS-7 cells.
2.2. Staining of transfected COS-7 cells
COS-7 cells were grown to conﬂuence and used to seed 4-
chamber slides (Nunc, Rochester, NY, USA) with 1  105 cells per
chamber in a total of 1.2 ml pre-warmed COS cell growth media
[17], and cultured for 24 h at 37 8C, 5% CO2. DNA complexes were
prepared in 500ml serum-free medium with 3.8 mg DNA, 5ml
chloroquine and 3ml DEAE/dextran. The cell layer was washed in
PBS and the DNA complex added for 3 h incubation at 37 8C, 5%
CO2. DMSO was added at 10% in PBS for 2 min, removed and
replaced with complete growth medium for 40 h incubation at
37 8C, 5% CO2.
The cell layer was washed in PBS and the chambers carefully
removed from the slides. The cellswere ﬁxed in acetone for 10 min,
washed and blocked with 1% BSA in PBS for 1 h at room
temperature, then washed three times in PBS. The relevant
primary mAb, diluted 1:10 in blocking buffer, was added to the
cells with incubation for 1 h at room temperature. Cells were
washed in PBS and then incubated with biotinylated mouse anti-
IgG secondary antibody for 30 min. Incubation with the macro-
molecular avidin-biotinylated enzyme ‘ABC’ conjugate (Vector
Labs, Burlingame, CA, USA) followed for 30 min, prior to
development with the NovaRed chromogen system (Vector Labs)
to visualize peroxidase in the tissue sections. Washes with PBS
took place between each step. Slides were washed in SuperQ H2O
before mounting.
3. Results
3.1. Cloning of turkey CD8a cDNA
Screening of the turkey cDNA library identiﬁed three positive
clones for CD8a which were sequenced with plasmid-speciﬁc
primers. Sequence was obtained for the full-length coding
sequence plus 43 nucleotides (nt) of 50 UTR.
Sequence comparisons (Fig. 1) showed that identity between
turkey CD8a and human CD8a was 48.5% and 29.6% at the nt and
amino acid (aa) levels, respectively. Identity between turkey and
mouse CD8a was 50.7% and 26.6% at the nt and aa levels,
respectively. Mammalian and avian CD8a shared eight conserved
cysteine residues.
Identity between chicken and turkey CD8a was 92% at the nt
level and 86.8% at the aa level (31/236 aa differences, Fig. 1). There
was one aa insertion of a lysine at position 159 in the turkey
sequence, compared to the chicken sequence, in a proline/serine/
threonine-rich region previously identiﬁed in the chicken [7]. In
this region there were 16/42 aa changes between the chicken and
the turkey, with two serine, two proline and no threonine
substitutions. Only one aa replacement was present in the
transmembrane region [7]. The tyrosine protein kinase-binding
site [18] was completely conserved between the chicken and
turkey. The turkey CD8a sequencewas submitted to Ensembl with
Acc. no. AM884251.
3.2. Cloning of turkey CD28 cDNA
Screening of the turkey cDNA library identiﬁed six positive
clones for turkey CD28. Sequencing of these clones generated the
whole coding sequence of turkey CD28 together with 66 nt of 50
UTR and 113 nt of 30 UTR.
Sequence comparisons (Fig. 2) showed that identity between
turkey and human CD28 was 59.8% and 50.4% at the nt and aa
levels, respectively. Turkey and murine CD28 shared 54.7% nt and
48.4% aa identity, respectively. Chicken and turkey CD28 showed
96.1% and 95.5% (10/221 aa differences) identity at the nt and aa
levels, respectively.
The extracellular MYPPPY motif in the complementarity-
determining region, CDR3, of the V-like domain was conserved
between all four CD28 sequences. There were ﬁve cysteines
present in the avian sequences. Four of these were present in the
predicted mature proteins and were conserved in human and
mouse CD28. Both chicken and turkey CD28 lacked two
cysteines in their mature proteins compared to mammals.
One of these cysteine residues formed an inter-molecular
disulphide bond for homodimer formation in mammalian
CD28. Therefore, both avian CD28 molecules could be expressed
as monomers [10]. Like mammalian CD28, the extracellular
regions of chicken and turkey CD28 contained seven potential
N-linked glycosylation sites, compared to six in mammals, three
of which were conserved in location and two in aa sequence. The
turkey CD28 sequence was submitted to Ensembl with Acc. no.
AM884252.
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Fig. 1. Comparison of the predicted aa sequences of human, murine, chicken and turkey CD8a. Shaded areas represent conservation of aa similarity; the darker the shading,
themore conserved the residue across species. Dashes indicate gaps in the alignment. Cysteine residues in the avian predicted proteins are indicatedwith asterisks. A proline/
serine/threonine-rich region is shown overlined. The tyrosine protein kinase-binding site [18] is showndouble over-lined and the transmembrane domain underlined [7]. The
accession numbers of the cDNA sequences used are as follows: human, BC025715; mouse, NM_001081110; chicken, NM_205235; turkey, AM884251.
Fig. 2. Comparison of the predicted aa sequences of human, murine, chicken and turkey CD28. Shaded areas represent conservation of aa similarity; the darker the shading,
themore conserved the residue across species. Dashes indicate gaps in the alignment. Conserved cysteine residues in the avian predicted proteins are indicatedwith asterisks.
The MYPPPY motif is shown double over-lined. Potential N-linked glycosylation sites in the avian sequences are indicated by +++. The accession numbers of the cDNA
sequences used are as follows: human, NM_006139; mouse, NM_007642; chicken, NM_205311; turkey, AM884252.
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Fig. 3. Comparison of the predicted aa sequences of human,murine, chicken and turkey CD4. Shaded areas represent conservation of aa similarity; the darker the shading, the
more conserved the residue across species. Dashes indicate gaps in the alignment. Conserved cysteine residues in the avian predicted proteins are indicated with asterisks.b-
strands of the V domains 1–4 of human CD4 are shown overlined. The tyrosine protein kinase-binding site [18] is shown double-overlined, a di-leucine motif [20] overlined
with a bar and the transmembrane domain underlined [4]. Potential N-linked glycosylation sites in the avian sequences are indicated by +++, and those conserved between
both species by +++. The accession numbers of the cDNA sequences used are as follows: human, NM_000616; mouse, NM_013488; chicken, Y12012; turkey, AM884253.
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3.3. Cloning of turkey CD4 cDNA
ScreeningoftheturkeycDNAlibraryidentiﬁedtwopositiveclones
for CD4, which were sequenced with plasmid-speciﬁc and insert-
speciﬁcprimers.A full lengthpredictedproteincoding sequencewas
obtained, along with 145 nt of 50 UTR and 166 nt of 30 UTR.
Sequence comparisons (Fig. 3) showed that sequence identity
between turkey and human CD4was 44.7% and 22.4% at the nt and
Fig. 4. Immunostaining of transfected COS-7 cells with anti-chicken CD marker monoclonal antibodies. COS-7 cells were transfected with (A) pCI-neo containing chicken
CD8a; (B) pCI-neo containing turkey CD8a; (C) pCI-neo alone; (D) untransfected; (E) pCI-neo containing chicken CD28; (F) pCI-neo containing turkey CD28; (G) pCI-neo
alone; (H) untransfected. (A–D) COS-7 cells stained with the anti-chicken CD8a monoclonal antibody, 11–39. (E–H) COS-7 cells stained with the anti-chicken CD28
monoclonal antibody, AV7. Magniﬁcation 250.
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aa levels, respectively. Turkey and murine CD4 shared 46.7% and
22.7% nt and aa identity, respectively (Fig. 3). Identity between
chicken and turkey CD4 was 91.3% at the nt and 84.2% at the aa
level (77/486 differences), respectively.
There are 14 cysteines in chicken CD4. All were conserved
between chicken and turkey, except for a single cysteine at
position 10 in chicken CD4 which was absent in the turkey. Only
seven cysteines were conserved between the avian and mamma-
lian CD4 molecules. Like mammalian CD4, the chicken CD4
extracellular region consists of four Ig-like domains [19]. While aa
replacements between chicken and turkey CD4 appeared ran-
domly distributed across themolecule andwithin the predictedb-
strands of the V domains, only two replacements occurred in the
transmembrane region between residues 431–454. After T cell
activation, CD4 is internalized [20]. In mammals, this requires the
phosphorylation of two serine residues associated with a di-
leucine motif [21] in the cytoplasmic tail. Both chicken and turkey
CD4 had the conserved di-leucine motif, although they lacked the
serine residues. Two nearby tyrosine residues may be used in the
chicken [19], and these were both conserved in the turkey. The
tyrosine protein kinase-binding site [18] was completely con-
served between the chicken and turkey. Therewere seven and nine
potential N-linked glycosylation sites in the chicken and turkey,
respectively, and six of them were conserved between the two
species. The turkey CD4 sequence was submitted to Ensembl with
Acc. no. AM884253.
3.4. Anti-chicken CD8a and CD28 mAb speciﬁcally cross-react with
turkey CD8a and CD28, respectively
COS-7 cells were either transfected with pCI-neo containing
turkey or chicken CD8a, empty vector alone or untransfected. The
resulting transfected or untransfected cells were then stained with
an anti-chicken CD8a mAb, 11–39 [22] (Fig. 4). COS-7 cells
expressing either chicken or turkey CD8a stained strongly with
anti-chicken CD8a.
Similarly, COS-7 cells were either transfected with pCI-neo
containing turkey or chicken CD28, empty vector alone or
untransfected. The resulting transfected or untransfected cells
were stained with an anti-chicken CD28 mAb, AV7 [10] (Fig. 4).
COS-7 cells expressing either chicken or turkey CD28 stained
strongly with anti-chicken CD28.
4. Discussion
Turkeys and chickens are phylogenetically closely related, both
being members of the order Galliformes. It is therefore to be
expected that some anti-chicken mAbs will cross-react with the
equivalent turkey antigens, as has been demonstrated by several
groups [13–15]. In our studies, where cross-reactivity was
observed, ampliﬁcation of the gene encoding the turkey ortholo-
gue of the chicken antigen was attempted by RT-PCR and Genome
Walking [16]. Using this approach, partial cDNA sequences of
turkey CD4, CD8a and CD28were previously characterized [16]. In
this study, these sequences were used as probes to screen a novel
turkey cDNA library. The resulting clones were sequenced and full-
length coding sequences of turkey CD4, CD8a and CD28 were
identiﬁed. In each case the predicted turkey proteins showed very
high aa identity to their chicken orthologues, suggesting both that
the molecules would have conserved functions in the two species,
and conﬁrming that reagents to the chicken CD markers have the
potential to cross-react with their turkey orthologues.
The functions of chicken and turkey CD4 are likely to be
conserved. Turkey CD4 has more potential N-glycosylation sites
than chicken CD4. Thirteen of fourteen cysteines in chicken CD4
are conserved in turkey CD4. All of the aa residues thought to play a
role in internalization of CD4 in the chicken are conserved in the
turkey molecule. Finally, the tyrosine protein kinase-binding site,
crucial for downstream signalling after CD4 engagement and
therefore the optimum response of CD4 T cells to antigen, is
completely conserved between both species.
Turkey and chicken CD8a both have ten conserved cysteines,
and the tyrosine protein kinase-binding site is completely
conserved also. Two regions in human CD8a are important in
binding thea3 domain of MHC class I, aa 47–56 and 76–81 [23]. In
human CD8a, if some of these residues are changed for acidic
residues, binding to MHC class I is abolished [23]. Although there
are several aa differences between turkey and chicken CD8a in
these regions, none of the substitutions are for acidic residues.
Again, this suggests that the functions of turkey and chicken CD8a
are conserved.
The six potential N-linked glycosylation sites, the four cysteine
residues, and theMYPPPYmotif (thought to be critical in binding of
CD28 and CTLA-4 to their ligands, the B7 family) in chicken CD28
are all conserved in turkey CD28, again suggesting conservation of
biological function.
The large panel of reagents now available in the chicken’s
‘‘immunological toolbox’’ provides potential tools to investigate
the turkey’s immune response. However, cross-reactivity of anti-
chicken CD marker mAb with turkey cells is variable. Of several
anti-chicken CD8a mAb, only two cross-react with turkey CD8 a
through FACS analysis (3–298 and 11–39) [14,24]. We recently
used the anti-chicken CD8amAb 11–39 to characterize changes in
CD8 T cells in the footpads of turkeys suffering from footpad
dermatitis [15]. This study has shown that this cross-reactivitywas
speciﬁc for turkey CD8a, reinforcing our conclusions [15] and
similarly that AV7, an anti-chicken CD28 mAb, speciﬁcally cross-
reacted with turkey CD28. These mAb (11–39 and AV7) can
therefore be used with conﬁdence to study cells expressing CD8a
or CD28 in the turkey and are tools to study the immune response
to any pathogen of turkeys. For example, we have used thesemAbs
to investigate the immune response of turkeys to infectionwith the
obligate extracellular protozoan parasite, Histomonas meleagridis
(Powell et al., submitted). Further, the cDNA sequences for turkey
CD4, CD8a and CD28 can be used to develop real-time quantitative
RT-PCR assays to measure expression of these molecules at the
mRNA level in turkey tissues and cells.
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